Aclaris Therapeutics' stock jumps on positive data for drug developed by St. Louis-based unit
January 20, 2021 at 15:31 PM EST
The drug was developed by St. Louis-based Aclaris Life Sciences Inc., formerly Confluence Life Sciences Inc., which Aclaris acquired in 2017.
